Please select the option that best describes you:
Did NRG LU004 demonstrate safety with hypofractionated lung radiation and concurrent ICI?
Can you explain the expansion cohorts into larger trials and the current amendments to the the protocol?
Answer from: Radiation Oncologist at Academic Institution
We reported the initial safety results at ASCO in 2022 after the trial was completed in 2021. There are no DLT signal and safety concerns of combining durvalumab with radiotherapy, whether it is conventionally fractionated or hypofractionated. The manuscript is under preparation incorporating some b...
Sign in or Register to read more